SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 72 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,093,000 | -17.4% | 60,870 | -45.7% | 0.07% | -25.6% |
Q3 2017 | $1,324,000 | +727.5% | 112,170 | +636.4% | 0.09% | +800.0% |
Q2 2017 | $160,000 | -94.7% | 15,233 | -94.4% | 0.01% | -93.8% |
Q1 2017 | $3,014,000 | +758.7% | 274,033 | +957.8% | 0.16% | +671.4% |
Q4 2016 | $351,000 | -62.8% | 25,905 | -66.2% | 0.02% | -58.8% |
Q3 2016 | $943,000 | +4.2% | 76,644 | -7.1% | 0.05% | +2.0% |
Q2 2016 | $905,000 | -54.5% | 82,540 | -54.6% | 0.05% | -60.6% |
Q1 2016 | $1,987,000 | -47.7% | 181,798 | -17.3% | 0.13% | -31.7% |
Q4 2015 | $3,802,000 | -5.6% | 219,881 | +8.5% | 0.19% | -6.1% |
Q3 2015 | $4,028,000 | +7.5% | 202,709 | -11.1% | 0.20% | +37.5% |
Q2 2015 | $3,748,000 | +116.1% | 228,144 | +104.8% | 0.14% | +108.7% |
Q1 2015 | $1,734,000 | +407.0% | 111,410 | +365.8% | 0.07% | +187.5% |
Q4 2014 | $342,000 | +67.6% | 23,918 | -16.2% | 0.02% | +60.0% |
Q1 2014 | $204,000 | +14.0% | 28,526 | -0.7% | 0.02% | +7.1% |
Q3 2013 | $179,000 | +98.9% | 28,726 | +109.4% | 0.01% | +27.3% |
Q2 2013 | $90,000 | – | 13,719 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 2,819,708 | $29,607,000 | 8.99% |
Rubric Capital Management LP | 577,900 | $6,068,000 | 1.25% |
Malaga Cove Capital, LLC | 84,241 | $882,000 | 0.53% |
NEA Management Company, LLC | 1,258,507 | $13,214,000 | 0.48% |
CLARK ESTATES INC/NY | 250,000 | $2,625,000 | 0.45% |
AlphaMark Advisors, LLC | 98,400 | $1,033,000 | 0.44% |
Ativo Capital Management LLC | 138,032 | $1,449,000 | 0.40% |
TFS CAPITAL LLC | 83,694 | $879,000 | 0.34% |
GLOBEFLEX CAPITAL L P | 103,949 | $1,091,000 | 0.27% |
Bowling Portfolio Management LLC | 135,021 | $1,418,000 | 0.21% |